Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery

Knowledge about prognostic factors in surgically treated patients with oropharyngeal squamous cell carcinoma (SCC) is limited. The purpose of this study was to identify influential factors on survival in a large cohort of patients with surgically treated oropharyngeal SCC.

[1]  E. Genden,et al.  Oncologic outcomes of surgically treated early‐stage oropharyngeal squamous cell carcinoma , 2016, Head & neck.

[2]  T. Helliwell,et al.  Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach , 2016, Head & neck.

[3]  D. O’Connell,et al.  Role of primary surgery in the treatment of advanced oropharyngeal cancer , 2016, Head & neck.

[4]  R. Carrau,et al.  Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes , 2016, Head & neck.

[5]  S. Stoeckli,et al.  Brush cytology for the detection of high‐risk HPV infection in oropharyngeal squamous cell carcinoma , 2015, Cancer cytopathology.

[6]  S. Stoeckli,et al.  Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy , 2015, European Archives of Oto-Rhino-Laryngology.

[7]  V. Grégoire,et al.  Biological Basis for Increased Sensitivity to Radiation Therapy in HPV-Positive Head and Neck Cancers , 2014, BioMed research international.

[8]  A. Psyrri,et al.  Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  H. Moch,et al.  Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity‐modulated chemoradiation , 2013, Head & neck.

[10]  P. Harari,et al.  Enhanced radiation sensitivity in HPV-positive head and neck cancer. , 2013, Cancer research.

[11]  T. Grob,et al.  HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  S. Stoeckli,et al.  Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16‐positivity , 2013, The Laryngoscope.

[13]  M. Pawlita,et al.  Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. , 2012, Cancer research.

[14]  B. Kremer,et al.  Next‐generation treatment strategies for human papillomavirus‐related head and neck squamous cell carcinoma: where do we go? , 2012, Reviews in medical virology.

[15]  G. Weinstein,et al.  Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient‐reported quality of life and function , 2012, Head & neck.

[16]  R. Hayden,et al.  Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter study , 2011, Head & neck.

[17]  G. Weinstein,et al.  Transoral robotic surgery and human papillomavirus status: Oncologic results , 2011, Head & neck.

[18]  E. Deutsch,et al.  Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity. , 2010, Cancer treatment reviews.

[19]  R. Fisher,et al.  Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  D. Elashoff,et al.  Histopathologic findings of HPV and p16 positive HNSCC , 2010, The Laryngoscope.

[21]  W. Westra,et al.  Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experience , 2010, Cancer.

[22]  J. Kao,et al.  HPV-induced oropharyngeal cancer, immune response and response to therapy. , 2010, Cancer letters.

[23]  F. Feng,et al.  Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence , 2010, Clinical Cancer Research.

[24]  William C. Perry,et al.  Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. , 2009, Archives of otolaryngology--head & neck surgery.

[25]  L. Terracciano,et al.  Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? , 2009, International journal of cancer.

[26]  Jens Overgaard,et al.  Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  E. Speel,et al.  Marked differences in survival rate between smokers and nonsmokers with HPV 16‐associated tonsillar carcinomas , 2008, International journal of cancer.

[28]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[29]  E. Munck‐Wikland,et al.  Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 , 2007, Molecular oncology.

[30]  C. R. Leemans,et al.  A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen , 2007, International journal of cancer.

[31]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[32]  Amy Y. Chen,et al.  Changes in Treatment of Advanced Oropharyngeal Cancer, 1985–2001 , 2007, The Laryngoscope.

[33]  L. Mariani,et al.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  W. Koch,et al.  Cystic metastasis from head and neck squamous cell cancer: A distinct disease variant? , 2006, Head & neck.

[35]  Jacques Bernier,et al.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.

[36]  G. Poissonnet,et al.  T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[37]  J. Laissue,et al.  Human papillomavirus positive squamous cell carcinoma of the oropharynx , 2001, Cancer.

[38]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[39]  F. Hoppe-Seyler,et al.  Cellular responses of HPV‐positive cancer cells to genotoxic anti‐cancer agents: Repression of E6/E7‐oncogene expression and induction of apoptosis , 1996, International journal of cancer.

[40]  R. Bristow,et al.  The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  G. Snow,et al.  Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology , 1992, International journal of cancer.

[42]  H. Yoshikawa,et al.  Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus Primers , 1991, Japanese journal of cancer research : Gann.

[43]  J. Stockman.  Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .